New carboxyphenyl-glycylboronic acid transition-state analog inhibitors, representative of a class of compounds effective against class C .beta.-lactamase AmpC. The new compounds improve inhibition by over two-orders of magnitude compared to analogous glycylboronic acids, with Ki values as low as 1 nM.